Psyence Biomedical Ltd [NASDAQ: PBM] closed the trading session at $1.58 on 2025-11-26. The day’s price range saw the stock hit a low of $1.46, while the highest price level was $1.61.
The stocks have a year to date performance of -93.92 percent and weekly performance of -43.37 percent. The stock has been moved at -69.73 percent over the last six months. The stock has performed -52.41 percent around the most recent 30 days and changed -46.80 percent over the most recent 3-months.
If compared to the average trading volume of 909.53K shares, PBM reached to a volume of 230243 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Psyence Biomedical Ltd [PBM]:
The Price to Book ratio for the last quarter was 0.25, with the Price to Cash per share for the same quarter was set at 3.84.
PBM stock trade performance evaluation
Psyence Biomedical Ltd [PBM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -43.37. With this latest performance, PBM shares dropped by -52.41% in over the last four-week period, additionally sinking by -69.73% over the last 6 months – not to mention a drop of -90.60% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PBM stock in for the last two-week period is set at 29.45, with the RSI for the last a single of trading hit 0.3011, and the three-weeks RSI is set at 0.3217 for Psyence Biomedical Ltd [PBM]. The present Moving Average for the last 50 days of trading for this stock 3.1115, while it was recorded at 1.5800 for the last single week of trading, and 4.6548 for the last 200 days.
Psyence Biomedical Ltd (PBM) Capital Structure & Debt Analysis
Psyence Biomedical Ltd (PBM) Efficiency & Liquidity Metrics
Based on Psyence Biomedical Ltd’s (PBM) latest financial statements, the Debt-to-Equity Ratio is 0.00%, indicating its reliance on debt financing relative to shareholder equity.
Psyence Biomedical Ltd (PBM) Efficiency & Liquidity Metrics
Psyence Biomedical Ltd [PBM]: Institutional Ownership
There are presently around $10.06%, or 10.08%% of PBM stock, in the hands of institutional investors. The top three institutional holders of PBM stocks are: ADVISORSHARES INVESTMENTS LLC with ownership of 0.46 million shares, which is approximately 23.9034%. CANTOR FITZGERALD, L. P., holding 0.34 million shares of the stock with an approximate value of $$0.1 million in PBM stocks shares; and CANTOR FITZGERALD, L. P., currently with $$6866.0 in PBM stock with ownership which is approximately 1.1814%.
